Femasys (FEMY) Research & Development (2020 - 2025)
Femasys (FEMY) posted Research & Development of $984977.0 for Q2 2025, up 2.69% on a QoQ basis from $959162.0 in Q1 2025, and down 50.15% year-over-year from $2.0 million in Q2 2024.
Femasys (FEMY) Research & Development (2020 - 2025) Analysis & Trends
Femasys' Research & Development history runs 6 years deep, the most recent figure standing at $984977.0 for Q2 2025.
- Quarterly Research & Development fell 50.15% year-over-year to $984977.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $9.6 million (down 5.41% YoY) and the FY2025 annual result came in at $7.6 million, down 7.78% from the prior year.
- Research & Development was $984977.0 for Q2 2025 at Femasys, up from $959162.0 in the prior quarter.
- Across five years, Research & Development topped out at $6.8 million in Q4 2023 and bottomed at -$2.8 million in Q4 2021.
- A 5-year average of $1.2 million and a median of $927015.0 in 2021 frame the typical range for Research & Development.
- Peak annual rise in Research & Development reached 6586.1% in 2021, while the deepest fall reached 9953.79% in 2021.
- Femasys' Research & Development stood at -$2.8 million in 2021, then jumped by 145.06% to $1.3 million in 2022, then jumped by 431.93% to $6.8 million in 2023, then slipped by 20.63% to $5.4 million in 2024, then plunged by 81.65% to $984977.0 in 2025.
- Business Quant data shows FEMY's Research & Development at $984977.0 in Q2 2025, $959162.0 in Q1 2025, and $5.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -245.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 249.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 94.27 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 189.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 98.66 Mn |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 984,977.00 |
| Mar 31, 2025 | 959,162.00 |
| Dec 31, 2024 | 5.37 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 6.76 Mn |
| Sep 30, 2023 | 70,883.00 |
| Jun 30, 2023 | 128,899.00 |
| Mar 31, 2023 | 1.54 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 90,374.00 |
| Jun 30, 2022 | 63,177.00 |
| Mar 31, 2022 | 68,863.00 |
| Dec 31, 2021 | -2.82 Mn |
| Sep 30, 2021 | 43,284.00 |
| Jun 30, 2021 | 894,868.00 |
| Mar 31, 2021 | 22,819.00 |
| Dec 31, 2020 | 28,636.00 |
| Sep 30, 2020 | 995,620.00 |